Skip to Content

Buprenorphine and Naloxone Tablets

Last Updated: January 23, 2013
Status: Discontinued

Products Affected - Description

Suboxone tablets, Reckitt Benckiser Pharmaceuticals - to be discontinued 2013
Buprenorphine 2 mg/naloxone 0.5 mg, 30 count (NDC 12496-1283-02)
Buprenorphine 8 mg/naloxone 2 mg, 30 count (NDC 12496-1306-02)

Reason for the Shortage

  • Reckitt Benckiser Pharmaceuticals is discontinuing Suboxone Tablets due to increased rates of accidental exposure in children compared to Suboxone Film. The company is working with FDA to ensure transition of patients from tablets to film is as smooth as possible. The company expects to discontinue the tablets in March 2013.
  • Subutex (buprenorphine sublingual tablets) have been discontinued.
  • Suboxone Film is not affected by this discontinuation.
  • Generic buprenorphine sublingual tablets are not affected by this discontinuation.

Available Products

Suboxone tablets, Reckitt Benckiser Pharmaceuticals - to be discontinued in March 2013
Buprenorphine 2 mg/naloxone 0.5 mg, 30 count (NDC 12496-1283-02)
Buprenorphine 8 mg/naloxone 2 mg, 30 count (NDC 12496-1306-02)

Estimated Resupply Dates

Reckitt Benckiser Pharmaceuticals continues to have supply but plans to discontinue product in mid-March, 2013.  

Related Shortages

Updated

January 23, 2013; October 9, 2012, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide